Lowest Price Guaranteed
Pages
423
Last Updated
August 2026
View Count
31983
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Key Market Segmentation
3.7. Robust Quality Control
3.8. Limitations
4. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Exoskeletons
6.3. History of Exoskeletons
6.4. Classification of Exoskeletons
6.4.1. Based on Body Part Supported
6.4.2. Based on Form of Exoskeleton
6.4.3. Based on Mode of Operation
6.4.4. Based on Mobility
6.5. Features of Exoskeletons
6.6. Limitations of Exoskeletons
6.7. Applications of Exoskeletons
6.8. Future Aspects of Exoskeletons
7. MEDICAL EXOSKELETONS: MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Medical Exoskeletons: Overall Market Landscape
7.2.1. Analysis by Status of Development
7.2.2. Analysis by Type of Body Part Covered
7.2.3. Analysis by Mode of Operation
7.2.4. Analysis by Type of Body Part Covered and Mode of Operation
7.2.5. Analysis by Form of Exoskeleton
7.2.6. Analysis by Mode of Operation and Form of Exoskeleton
7.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
7.2.8. Analysis by Device Mobility
7.2.9. Analysis by Mode of Operation and Device Mobility
7.2.10. Analysis by Form of Exoskeleton and Device Mobility
7.2.11. Analysis by Type of Body Part Covered and Device Mobility
7.2.12. Analysis by User-Machine Interface
7.2.13. Analysis by Type of Body Part Covered and User-Machine Interface
7.2.14. Analysis by Mode of Operation and User-Machine Interface
7.2.15. Analysis by Availability of Advanced Features
7.2.16. Analysis by End User
7.2.17. Analysis by Patient Age Group
7.2.18. Analysis by Exoskeleton Setting for Patients
7.2.19. Analysis by Breakthrough Designation
7.3. Medical Exoskeletons: Developer Landscape
7.3.1. Analysis by Year of Establishment
7.3.2. Analysis by Company Size
7.3.3. Analysis by Location of Headquarters
7.3.4. Analysis by Company Size and Location of Headquarters (Region)
7.3.5. Analysis by Company Ownership
7.3.6. Analysis by Location of Headquarters (Region) and Company Ownership
7.3.7. Analysis by Additional Services Offered
7.3.8. Most Active Players: Analysis by Number of Medical Exoskeletons
8. NON-MEDICAL EXOSKELETONS: MARKET LANDSCAPE
8.1. Chapter Overview
8.2. Non-Medical Exoskeletons: Overall Market Landscape
8.2.1. Analysis by Status of Development
8.2.2. Analysis by Type of Body Part Covered
8.2.3. Analysis by Body Part Supported
8.2.4. Analysis by Mode of Operation
8.2.5. Analysis by Form of Exoskeleton
8.2.6. Analysis by Type of Body Part Covered and Mode of Operation
8.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
8.2.8. Analysis by Mode of Operation and Form of Exoskeleton
8.2.9. Analysis by Application Area
8.2.10. Analysis by Mode of Operation and Application Area
8.3. Non-Medical Exoskeletons: Developer Landscape
8.3.1. Analysis by Year of Establishment
8.3.2. Analysis by Company Size
8.3.3. Analysis by Company Size and Employee Count
8.3.4. Analysis by Location of Headquarters
8.3.5. Analysis by Company Size and Location of Headquarters (Region)
8.3.6. Analysis by Company Ownership
8.3.7. Analysis by Location of Headquarters (Region) and Company Ownership
8.3.8. Most Active Players: Analysis by Number of Non-Medical Exoskeletons
8.3.9. Most Active Players: Analysis by Number of Exoskeletons
9. MEDICAL EXOSKELETONS: PRODUCT COMPETITVENESS ANALYSIS
9.1. Chapter Overview
9.2. Assumptions and Key Parameters
9.3. Methodology
9.4. Medical Exoskeletons: Product Competitiveness Analysis
9.4.1. Product Competitiveness Analysis: Upper Body Medical Exoskeletons
9.4.1.1. Product Competitiveness Analysis: Powered Upper Body Exoskeletons
9.4.1.2. Product Competitiveness Analysis: Passive Upper Body Exoskeletons
9.4.1.3. Product Competitiveness Analysis: Hybrid Upper Body Exoskeletons
9.4.2. Product Competitiveness Analysis: Lower Body Exoskeletons
9.4.2.1. Product Competitiveness Analysis: Powered Lower Body Exoskeletons
9.4.2.2. Product Competitiveness Analysis: Passive Lower Body Exoskeletons
9.4.2.3. Product Competitiveness Analysis: Hybrid Lower Body Exoskeletons
9.4.3. Product Competitiveness Analysis: Full Body Medical Exoskeletons
10. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES
10.1. Chapter Overview
10.2. CYBERDYNE
10.2.1. Company Overview
10.2.2. Financial Information
10.2.3. Product Portfolio
10.2.4. Recent Developments and Future Outlook
10.3. Ekso Bionics
10.3.1. Company Overview
10.3.2. Financial Information
10.3.3. Product Portfolio
10.3.4. Recent Developments and Future Outlook
10.4. ExoAtlet
10.4.1. Company Overview
10.4.2. Product Portfolio
10.4.3. Recent Developments and Future Outlook
10.5. Fourier Intelligence
10.5.1. Company Overview
10.5.2. Product Portfolio
10.5.3. Recent Developments and Future Outlook
10.6. Gloreha
10.6.1. Company Overview
10.6.2. Product Portfolio
10.6.3. Recent Developments and Future Outlook
10.7. Guangzhou Yikang
10.7.1. Company Overview
10.7.2. Product Portfolio
10.7.3. Recent Developments and Future Outlook
10.8. Hexar Humancare
10.8.1. Company Overview
10.8.2. Product Portfolio
10.8.3. Recent Developments and Future Outlook
10.9. Hocoma
10.9.1. Company Overview
10.9.2. Product Portfolio
10.9.3. Recent Developments and Future Outlook
10.10. Tyromotion
10.10.1. Company Overview
10.10.2. Product Portfolio
10.10.3. Recent Developments and Future Outlook
11. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES
11.1. Chapter Overview
11.2. Bionic Yantra
11.2.1. Company Overview
11.2.2. Product Portfolio
11.3. MediTouch
11.3.1. Company Overview
11.3.2. Product Portfolio
11.4. Milebot Robotics
11.4.1. Company Overview
11.4.2. Product Portfolio
11.5. Myomo
11.5.1. Company Overview
11.5.2. Product Portfolio
11.6. Neofect
11.6.1. Company Overview
11.6.2. Product Portfolio
11.7. NextStep Robotics
11.7.1. Company Overview
11.7.2. Product Portfolio
11.8. ReWalk Robotics
11.8.1. Company Overview
11.8.2. Product Portfolio
11.9. Rex Bionics
11.9.1. Company Overview
11.9.2. Product Portfolio
11.10. Roam Robotics
11.10.1. Company Overview
11.10.2. Product Portfolio
11.11. Trexo Robotics
11.11.1. Company Overview
11.11.2. Product Portfolio
11.12. U&O Technologies
11.12.1. Company Overview
11.12.2. Product Portfolio
12. MEDICAL EXOSKELETONS: PARTNERSHIPS AND COLLABORATIONS
12.1. Chapter Overview
12.2. Partnership Models
12.3. Medical Exoskeletons: List of Partnerships and Collaborations
12.3.1. Analysis by Year of Partnership
12.3.2. Analysis by Type of Partnership
12.3.3. Analysis by Year and Type of Partnership
12.3.4. Analysis by Purpose of Partnership
12.3.5. Analysis by Type and Purpose of Partnership
12.3.6. Analysis by Type of Partner
12.3.7. Analysis by Year of Partnership and Type of Partner
12.3.8. Analysis by Type of Non-Industry Players
12.3.9. Most Active Players: Distribution by Number of Partnerships
12.3.10. Analysis by Geography
12.3.10.1. Local and International Agreements
12.3.10.2. Intracontinental and Intercontinental Agreements
13. PATENT ANALYSIS
13.1. Chapter Overview
13.2. Scope and Methodology
13.3. Exoskeletons: Patent Analysis
13.3.1. Analysis by Patent Application Year
13.3.2. Analysis by Patent Publication Year
13.3.3. Analysis by Type of Patent and Patent Publication Year
13.3.4. Analysis by Publication Time
13.3.5. Analysis by Patent Jurisdiction
13.3.6. Analysis by CPC symbols
13.3.7. Analysis by Type of Applicant
13.3.8. Leading Industry Players: Analysis by Number of Patents
13.3.9. Leading Non-Industry Players: Analysis by Number of Patents
13.3.10. Leading Patent Assignees: Analysis by Number of Patents
13.4. Exoskeletons: Patent Benchmarking
13.4.1. Analysis by Patent Characteristics
13.4.2. Exoskeleton: Patent Valuation
13.5. Leading Players by Number of Citations
14. BLUE OCEAN STRATEGY
14.1. Overview of Blue Ocean Strategy
14.1.1. Red Oceans
14.1.2. Blue Oceans
14.1.3. Comparison of Red Ocean Strategy and Blue Ocean Strategy
14.1.4. Medical Exoskeletons: Blue Ocean Strategy and Shift Tools
14.1.4.1. Strategy Canvas
14.1.4.2. Pioneer-Migrator-Settler (PMS) Map
14.1.4.3. Buyer Utility Map
15. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
15.1. Chapter Overview
15.2. Market Drivers
15.3. Market Restraints
15.4. Market Opportunities
15.5. Market Challenges
15.6. Conclusion
16. GLOBAL EXOSKELETONS MARKET
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. Global Exoskeletons Market, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
16.3.1. Scenario Analysis
16.3.1.1. Conservative Scenario
16.3.1.2. Optimistic Scenario
16.4. Key Market Segmentations
17. EXOSKELETONS MARKET, BY BODY PART COVERED
17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions
17.3. Overall Exoskeletons Market: Distribution by Body Part Covered
17.3.1. Overall Upper Body Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
17.3.2. Overall Lower Body Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
17.3.3. Overall Full Body Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
17.4. Medical Exoskeletons Market: Distribution by Body Part Covered
17.4.1. Medical Upper Body Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
17.4.2. Medical Lower Body Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
17.4.3. Medical Full Body Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
17.5. Non-Medical Exoskeletons Market: Distribution by Body Part Covered
17.5.1. Non-Medical Upper Body Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
17.5.2. Non-Medical Lower Body Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
17.5.3. Non-Medical Full Body Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
17.6. Data Triangulation and Validation
18. EXOSKELETONS MARKET, BY MODE OF OPERATION
18.1. Chapter Overview
18.2. Forecast Methodology and Key Assumptions
18.3. Overall Exoskeletons Market: Distribution by Mode of Operation
18.3.1. Overall Powered Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
18.3.2. Overall Passive Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
18.3.3. Overall Hybrid Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
18.4. Medical Exoskeletons Market: Distribution by Mode of Operation
18.4.1. Medical Powered Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
18.4.2. Medical Passive Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
18.4.3. Medical Hybrid Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
18.5. Non-Medical Exoskeletons Market: Distribution by Mode of Operation
18.5.1. Non-Medical Powered Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
18.5.2. Non-Medical Passive Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
18.5.3. Non-Medical Hybrid Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
18.6. Data Triangulation and Validation
19. EXOSKELETON MARKETS, BY FORM OF EXOSKELETON
19.1. Chapter Overview
19.2. Forecast Methodology and Key Assumptions
19.3. Overall Exoskeletons Market: Distribution by Form of Exoskeleton
19.3.1. Overall Rigid Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
19.3.2. Overall Soft Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
19.4. Medical Exoskeletons Market: Distribution by Form of Exoskeleton
19.4.1. Medical Rigid Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
19.4.2. Medical Soft Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
19.5. Non-Medical Exoskeletons Market: Distribution by Form of Exoskeleton
19.5.1. Non-Medical Rigid Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
19.5.2. Non-Medical Soft Exoskeletons: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
19.6. Data Triangulation and Validation
20. EXOSKELETON MARKETS, BY MOBILITY
20.1. Chapter Overview
20.2. Forecast Methodology and Key Assumptions
20.3. Medical Exoskeletons Market: Distribution by Mobility
20.3.1. Medical Fixed/ Supported Exoskeleton: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
20.3.2. Medical Mobile / Overground Walking Exoskeleton: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
20.4. Data Triangulation and Validation
21. EXOSKELETONS MARKET, BY END USER
21.1. Chapter Overview
21.2. Forecast Methodology and Key Assumptions
21.3. Overall Exoskeletons Market: Distribution by End User
21.4. Exoskeletons Market for Patients: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
21.5. Exoskeletons Market for Healthcare Providers: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
21.6. Exoskeletons Market for Industry Workers: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
21.7. Exoskeletons Market for Military Personnel: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
21.8. Exoskeletons Market for Other End Users: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
21.9. Data Triangulation and Validation
22. EXOSKELETONS MARKET, BY KEY GEOGRAPHICAL REGIONS
22.1. Chapter Overview
22.2. Forecast Methodology and Key Assumptions
22.3. Overall Exoskeletons Market: Distribution by Key Geographical Regions
22.3.1. North America, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
22.3.2. Europe, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
22.3.3. Asia-Pacific, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
22.3.4. Rest of the World, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
22.4. Data Triangulation and Validation
23. CONCLUSION
24. EXECUTIVE INSIGHTS
24.1. Chapter Overview
24.2. Company A
24.2.1. Company Snapshot
24.2.2. Interview Transcript: Co-Founder and Chief Executive Officer
24.3. Company B
24.3.1. Company Snapshot
24.3.2. Interview Transcript: Director of Business Planning and Development
24.4. Company C
24.4.1. Company Snapshot
24.4.2. Interview Transcript: Vice President of Sales and Marketing
24.5. Company D
24.5.1. Company Snapshot
24.5.2. Interview Transcript: Founder and Director
24.6. Company E
24.6.1. Company Snapshot
24.6.2. Interview Transcript: Marketing and Design Manager
24.7. Company F
24.7.1. Company Snapshot
24.7.2. Interview Transcript: Founder and Chief Executive Officer
24.8. Company G
24.8.1. Company Snapshot
24.8.2. Interview Transcript: Founder and Chief Executive Officer
24.9. Company H
24.9.1. Company Snapshot
24.9.2. Interview Transcript: Founder and Chief Executive Officer
24.10. Company I
24.10.1. Company Snapshot
24.10.2. Interview Transcript: Founder
24.11. Company J
24.11.1. Company Snapshot
24.11.2. Interview Transcript: Co-founder & Chief Scientific Officer
24.12. Company K
24.12.1. Company Snapshot
24.12.2. Interview Transcript: Division Head
24.13. Company L
24.13.1. Company Snapshot
24.13.2. Interview Transcript: Scientific Chair
24.14. Company M
24.14.1. Company Snapshot
24.14.2. Interview Transcript: Professor
24.15. Company N
24.15.1. Company Snapshot
24.15.2. Interview Transcript: Associate Professor
24.16. Company O
24.16.1. Company Snapshot
24.16.2. Interview Transcript: Wearable Robotics Researcher / Engineer
25. APPENDIX I: BLUE OCEAN STRATEGY AND SHIFT TOOLS
25.1. Chapter Overview
25.2. Blue Ocean Strategy and Shift Tools
25.2.1. Value Innovation
25.2.2. Four Action Framework
25.2.3. Eliminate-Raise-Reduce-Create (ERRC) Grid
25.2.4. Six Path Framework
25.2.5. Three Tiers of Non-customers
25.3. Sequence of Blue Ocean Strategy
25.3.1. The Price Corridor of the Mass
25.3.2. Four Hurdles to Strategy Execution
25.3.3. Tipping Point Leadership
25.3.4. Fair Process
26. APPENDIX II: TABULATED DATA
27. APPENDIX III: LIST OF COMPANIES AND ORGANIZATION
Figure 2.1 Research Methodology: Project Methodology
Figure 2.2 Research Methodology: Data Sources for Secondary Research
Figure 2.3 Research Methodology: Robust Quality Control
Figure 3.1 Market Dynamics: Forecast Methodology
Figure 3.2 Market Dynamics: Key Market Segmentation
Figure 4.1 Lessons Learnt from Past Recessions
Figure 5.1 Executive Summary: Medical Exoskeletons Market Landscape
Figure 5.2 Executive Summary: Non-Medical Exoskeletons Market Landscape
Figure 5.3 Executive Summary: Partnerships and Collaborations
Figure 5.4 Executive Summary: Patent Analysis
Figure 5.5 Executive Summary: Overall Market Forecast and Opportunity Analysis
Figure 5.6 Executive Summary: Medical Exoskeletons Market Forecast and Opportunity Analysis
Figure 5.7 Executive Summary: Non-Medical Exoskeletons Market Forecast and Opportunity Analysis
Figure 6.1 Types of Mobility Assistive Devices
Figure 6.2 Historical Events Related to Exoskeletons
Figure 6.3 Classification of Exoskeletons
Figure 6.4 Movements Supported by Lower Body, Upper Body and Full Body Exoskeletons
Figure 6.5 Components of a Powered / Robotic Exoskeletons
Figure 6.6 Features of Exoskeletons
Figure 6.7 Limitations of Exoskeletons
Figure 6.8 Applications of Exoskeleton
Figure 7.1 Medical Exoskeletons: Distribution by Status of Development
Figure 7.2 Medical Exoskeletons: Distribution by Type of Body Part Covered
Figure 7.3 Medical Exoskeletons: Distribution by Mode of Operation
Figure 7.4 Medical Exoskeletons: Distribution Type of Body Part Covered and Mode of Operation
Figure 7.5 Medical Exoskeletons: Distribution by Form of Exoskeleton
Figure 7.6 Medical Exoskeletons: Distribution by Mode of Operation and Form of Exoskeleton
Figure 7.7 Medical Exoskeletons: Distribution Type of Body Part Covered and Form of Exoskeleton
Figure 7.8 Medical Exoskeletons: Distribution by Device Mobility
Figure 7.9 Medical Exoskeletons: Distribution by Mode of Operation and Device Mobility
Figure 7.10 Medical Exoskeletons: Distribution by Form and Device Mobility
Figure 7.11 Medical Exoskeletons: Distribution by Type of Body Part Covered and Device Mobility
Figure 7.12 Medical Exoskeletons: Distribution by User-Machine Interface
Figure 7.13 Medical Exoskeletons: Distribution by Type of Body Part Covered and User-Machine Interface
Figure 7.14 Medical Exoskeletons: Distribution by Mode of Operation and User-Machine Interface
Figure 7.15 Medical Exoskeletons: Distribution by Availability of Advanced Features
Figure 7.16 Medical Exoskeletons: Distribution by End User
Figure 7.17 Medical Exoskeletons: Distribution by Patient Age Group
Figure 7.18 Medical Exoskeletons: Distribution by Exoskeleton Setting for Patients
Figure 7.19 Medical Exoskeletons: Distribution by Breakthrough Designation
Figure 7.20 Medical Exoskeleton Developers: Distribution by Year of Establishment
Figure 7.21 Medical Exoskeleton Developers: Distribution by Company Size
Figure 7.22 Medical Exoskeleton Developers: Distribution by Company Size and Employee Count
Figure 7.23 Medical Exoskeleton Developers: Distribution by Location of Headquarters (Region)
Figure 7.24 Medical Exoskeleton Developers: Distribution by Location of Headquarters (Country)
Figure 7.25 Medical Exoskeleton Developers: Distribution by Company Size and Location of Headquarters
Figure 7.26 Medical Exoskeleton Developers: Distribution by Company Ownership
Figure 7.27 Medical Exoskeleton Developers: Distribution by Location of Headquarters and Company Ownership
Figure 7.28 Medical Exoskeleton Developers: Distribution by Additional Services Offered
Figure 7.29 Most Active Players: Distribution by Number of Medical Exoskeleton
Figure 8.1 Non-Medical Exoskeletons: Distribution by Status of Development
Figure 8.2 Non-Medical Exoskeletons: Distribution by Type of Body Part Covered
Figure 8.3 Non-Medical Exoskeletons: Distribution by Body Part Supported
Figure 8.4 Non-Medical Exoskeletons: Distribution by Mode of Operation
Figure 8.5 Non-Medical Exoskeletons: Distribution by Form of Exoskeleton
Figure 8.6 Non-Medical Exoskeletons: Distribution by Type of Body Part Covered and Mode of Operation
Figure 8.7 Non-Medical Exoskeletons: Distribution by Type of Body Part Covered and Form of Exoskeleton
Figure 8.8 Non-Medical Exoskeletons: Distribution by Mode of Operation and Form of Exoskeleton
Figure 8.9 Non-Medical Exoskeletons: Distribution by Application Area
Figure 8.10 Non-Medical Exoskeletons: Distribution by Mode of Operation and Application Area
Figure 8.11 Non-Medical Exoskeleton Developers: Distribution by Year of Establishment
Figure 8.12 Non-Medical Exoskeleton Developers: Distribution by Company Size
Figure 8.13 Non-Medical Exoskeleton Developers: Distribution by Company Size and Employee Count
Figure 8.14 Non-Medical Exoskeleton Developers: Distribution by Location of Headquarters (Region)
Figure 8.15 Non-Medical Exoskeleton Developers: Distribution by Location of Headquarters (Country)
Figure 8.16 Non-Medical Exoskeleton Developers: Distribution by Company Size and Location of Headquarters
Figure 8.17 Non-Medical Exoskeleton Developers: Distribution by Company Ownership
Figure 8.18 Non-Medical Exoskeleton Developers: Distribution by Location of Headquarters and Company Ownership
Figure 8.19 Most Active Players: Distribution by Number of Exoskeletons
Figure 8.20 Most Active Players: Distribution by Number of Medical and Non-Medical Exoskeletons
Figure 9.1 Product Competitiveness Analysis: Powered Upper Body Exoskeletons (Peer Group I)
Figure 9.2 Product Competitiveness Analysis: Passive Upper Body Exoskeletons (Peer Group II)
Figure 9.3 Product Competitiveness Analysis: Hybrid Upper Body Exoskeletons (Peer Group III)
Figure 9.4 Product Competitiveness Analysis: Powered Lower Body Exoskeletons (Peer Group IV)
Figure 9.5 Product Competitiveness Analysis: Passive Lower Body Exoskeletons (Peer Group V)
Figure 9.6 Product Competitiveness Analysis: Hybrid Lower Body Exoskeletons (Peer Group VI)
Figure 9.7 Product Competitiveness Analysis: Full Body Exoskeleton (Peer Group VII)
Figure 10.1 CYBERDYNE: Annual Revenues, Since FY 2019 (JPY Billion)
Figure 10.2 CYBERDYNE: Distribution of Revenues by Business Segment, Since FY 2021
Figure 10.3 Ekso Bionics: Annual Revenues, Since FY 2018 – FY Q1 2023 (USD Billion)
Figure 10.4 Ekso Bionics: Distribution of Revenues by Business Segment, FY 2023
Figure 10.5 Panasonic: Annual Revenues, Since FY 2018 (JPY Billion)
Figure 12.1 Partnerships and Collaborations: Cumulative Year-wise Trend
Figure 12.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 12.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 12.4 Partnerships and Collaborations: Distribution by Purpose of Partnership
Figure 12.5 Partnerships and Collaborations: Distribution by Type and Purpose of Partnership
Figure 12.6 Partnerships and Collaborations: Distribution by Type of Partner
Figure 12.7 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Figure 12.8 Partnerships and Collaborations: Distribution by Type of Non-Industry Partner
Figure 12.9 Most Active Players: Distribution by Number of Partnerships
Figure 12.10 Partnerships and Collaborations: Local and International Agreements
Figure 12.11 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 13.1 Patent Analysis: Distribution by Type of Patent
Figure 13.2 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year
Figure 13.3 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year
Figure 13.4 Patent Analysis: Distribution by Type of Patent and Patent Publication Year
Figure 13.5 Patent Analysis: Distribution by Publication Time
Figure 13.6 Patent Analysis: Distribution by Patent Jurisdiction (Region)
Figure 13.7 Patent Analysis: Distribution by Patent Jurisdiction (Country)
Figure 13.8 Patent Analysis: Distribution by CPC Symbols
Figure 13.9 Patent Analysis: Distribution by Type of Applicant
Figure 13.10 Leading Industry Players: Distribution by Number of Patents
Figure 13.11 Leading Non-Industry Players: Distribution by Number of Patents
Figure 13.12 Leading Individual Assignees: Distribution by Number of Patents
Figure 13.13 Patent Benchmarking Analysis: Distribution of CPC Codes by Leading Industry Players
Figure 13.14 Patent Benchmarking Analysis: Distribution of CPC Codes by Leading Non- Industry Players
Figure 13.15 Patent Analysis: Distribution by Patent Age
Figure 13.16 Patent Analysis: Patent Valuation
Figure 14.1 Differences Between Red Ocean Strategy and Blue Ocean Strategy
Figure 14.2 Blue Ocean Strategy: Strategy Canvas
Figure 14.3 Blue Ocean Strategy: Pioneer-Migrator-Settler (PMS) Map
Figure 14.4 Blue Ocean Strategy: Buyer Utility Map
Figure 16.1 Standard Demand-Price Curve for Exoskeleton
Figure 16.2 Global Exoskeletons Market, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.3 Global Exoskeletons Market, Forecasted Estimates (2023- 2035), Conservative Scenario (USD Billion)
Figure 16.4 Global Exoskeletons Market, Forecasted Estimates (2023- 2035), Optimistic Scenario (USD Billion)
Figure 17.1 Overall Exoskeletons Market: Distribution by Body Part Covered, 2018, 2023 and 2035 (USD Billion)
Figure 17.2 Overall Exoskeletons Market for Upper Body Exoskeletons: Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 17.3 Overall Exoskeletons Market for Lower Body Exoskeletons: Historical Trends (Since 2018) and Future Estimates (2023- 2035) (USD Billion)
Figure 17.4 Overall Exoskeletons Market for Full Body Exoskeletons: Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 17.5 Medical Exoskeletons Market: Distribution by Body Part Covered, 2018, 2023 and 2035 (USD Billion)
Figure 17.6 Medical Exoskeletons Market for Upper Body Exoskeletons: Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 17.7 Medical Exoskeletons Market for Lower Body Exoskeletons: Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 17.8 Medical Exoskeletons Market for Full Body Exoskeletons: Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 17.9 Non-Medical Exoskeletons Market: Distribution by Body Part Covered, 2018, 2023 and 2035 (USD Billion)
Figure 17.10 Non-Medical Exoskeletons Market for Upper Body Exoskeletons: Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 17.11 Non-Medical Exoskeletons Market for Lower Body Exoskeletons: Historical Trends (Since 2018) and Future Estimates (2023- 2035) (USD Billion)
Figure 17.12 Non-Medical Exoskeletons Market for Full Body Exoskeletons: Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 18.1 Overall Exoskeletons Market: Distribution by Mode of Operation, 2018, 2023 and 2035 (USD Billion)
Figure 18.2 Overall Exoskeletons Market for Powered Exoskeletons, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 18.3 Overall Exoskeletons Market for Passive Exoskeletons, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 18.4 Overall Exoskeletons Market for Hybrid Exoskeletons, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 18.5 Medical Exoskeletons Market: Distribution by Mode of Operation, 2018, 2023 and 2035 (USD Billion)
Figure 18.6 Medical Powered Exoskeletons Market, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 18.7 Medical Passive Exoskeletons Market, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 18.8 Medical Hybrid Exoskeletons Market, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 18.9 Non-Medical Exoskeletons Market: Distribution by Mode of Operation, 2018, 2023 and 2035 (USD Billion)
Figure 18.10 Non-Medical Powered Exoskeletons Market, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 18.11 Non-Medical Passive Exoskeletons Market, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 18.12 Non-Medical Hybrid Exoskeletons Market, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 19.1 Overall Exoskeletons Market: Distribution by Form, 2018, 2023 and 2035 (USD Billion)
Figure 19.2 Overall Exoskeletons Market for Rigid Exoskeletons, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 19.3 Overall Exoskeletons Market for Soft Exoskeletons, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 19.4 Medical Exoskeletons Market: Distribution by Form, 2018, 2023 and 2035 (USD Billion)
Figure 19.5 Medical Rigid Exoskeletons Market, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 19.6 Medical Soft Exoskeletons Market, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 19.7 Non-Medical Exoskeletons Market: Distribution by Form, 2018, 2023 and 2035 (USD Billion)
Figure 19.8 Non-Medical Rigid Exoskeletons Market, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 19.9 Non-Medical Soft Exoskeletons Market, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 20.1 Medical Exoskeletons Market: Distribution by Mobility, 2018, 2023 and 2035 (USD Billion)
Figure 20.2 Medical Fixed / Supported Exoskeletons Market: Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 20.3 Medical Mobile / Overground Walking Exoskeletons Market: Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 21.1 Overall Exoskeletons Market: Distribution by End Users, 2018, 2023 and 2035 (USD Billion)
Figure 21.2 Exoskeletons Market for Patients, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 21.3 Exoskeletons Market for Healthcare Professionals, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 21.4 Exoskeletons Market for Industry Workers, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 21.5 Exoskeletons Market for Military Personnel, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 21.6 Exoskeletons Market for Other End Users, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 22.1 Overall Exoskeletons Market: Distribution by Geography, 2018, 2023 and 2035
Figure 22.2 Exoskeletons Market in North America, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 22.3 Exoskeletons Market in Europe, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 22.4 Exoskeletons Market in Asia-Pacific, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 22.5 Exoskeletons Market in Rest of the World, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Billion)
Figure 23.1 Concluding Remarks: Overall Medical Exoskeletons Market Landscape
Figure 23.2 Concluding Remarks: Overall Non-Medical Exoskeletons Market Landscape
Figure 23.3 Concluding Remarks: Partnerships and Collaborations
Figure 23.4 Concluding Remarks: Patent Analysis
Figure 23.5 Concluding Remarks: Market Forecast and Opportunity Analysis (I/II)
Figure 23.6 Concluding Remarks: Market Forecast and Opportunity Analysis (II/II)
Figure 25.1 Blue Ocean Strategy: Three Tiers of Non-customers
Figure 25.2 Blue Ocean Strategy: Sequence of Blue Ocean Strategy
Figure 25.3 Blue Ocean Strategy: The Price Corridor of The Mass
Table 6.1 Degrees of Freedom in Each Joint of Lower Exoskeletons
Table 6.2 Contrasting Characteristics: Medical and Non-Medical Exoskeletons
Table 6.3 Distinguishing Characteristics: Medical and Non-medical Exoskeletons
Table 7.1 Medical Exoskeletons: Information on Status of Development, Type of Body Part Covered and Mode of Operation
Table 7.2 Medical Exoskeletons: Information on Form, Device Mobility and User-Machine Interface
Table 7.3 Medical Exoskeletons: Information on Advanced Features and End Users
Table 7.4 Medical Exoskeletons: Information on Patient Age Group, Exoskeleton Setting for Patients and Breakthrough Designation
Table 7.5 Medical Exoskeletons: Information on Technology / Software, Maximum Weight of Exoskeleton, Maximum Weight Carrying Capacity and Dimensions
Table 7.6 Medical Exoskeletons: List of Developers
Table 7.7 Medical Exoskeletons: Information on Additional Services Offered
Table 8.1 Non-Medical Exoskeletons: Information on Status of Development, Type of Body Part Covered and Body Part Supported
Table 8.2 Non-Medical Exoskeletons: Information on Mode of Operation and Form of Exoskeleton
Table 8.3 Non-Medical Exoskeletons: Information on Application Area
Table 8.4 Non-Medical Exoskeletons: Information on Technology / Software, Maximum Weight of Exoskeleton, Maximum Weight Carrying Capacity and Dimensions
Table 8.5 Non-Medical Exoskeletons: List of Developers
Table 10.1 List of Exoskeleton Companies Profiled
Table 10.2 CYBERDYNE: Company Snapshot
Table 10.3 CYBERDYNE: Medical Exoskeleton Portfolio
Table 10.4 CYBERDYNE: Non-Medical Exoskeleton Portfolio
Table 10.5 CYBERDYNE: Recent Developments and Future Outlook
Table 10.6 Ekso Bionics: Company Snapshot
Table 10.7 Ekso Bionics: Medical Exoskeleton Portfolio
Table 10.8 Ekso Bionics: Non-Medical Exoskeleton Portfolio
Table 10.9 Ekso Bionics: Recent Developments and Future Outlook
Table 10.10 ExoAtlet: Company Snapshot
Table 10.11 ExoAtlet: Medical Exoskeleton Portfolio
Table 10.12 ExoAtlet: Non-Medical Exoskeleton Portfolio
Table 10.13 ExoAtlet: Recent Developments and Future Outlook
Table 10.14 Fourier Intelligence: Company Snapshot
Table 10.15 Fourier Intelligence: Medical Exoskeleton Portfolio
Table 10.16 Fourier Intelligence: Recent Developments and Future Outlook
Table 10.17 Gloreha: Company Snapshot
Table 10.18 Gloreha: Medical Exoskeleton Portfolio
Table 10.19 Gloreha: Recent Developments and Future Outlook
Table 10.20 Guangzhou YiKang: Company Snapshot
Table 10.21 Guangzhou YiKang: Medical Exoskeleton Portfolio
Table 10.22 Guangzhou YiKang: Recent Developments and Future Outlook
Table 10.23 Hexar Humancare: Company Snapshot
Table 10.24 Hexar Humancare: Medical Exoskeleton Portfolio
Table 10.25 Hexar Humancare: Non-Medical Exoskeleton Portfolio
Table 10.26 Hexar Humancare: Recent Developments and Future Outlook
Table 10.27 Hocoma: Company Snapshot
Table 10.28 Hocoma: Medical Exoskeleton Portfolio
Table 10.29 Hocoma: Recent Developments and Future Outlook
Table 10.30 Panasonic: Company Snapshot
Table 10.31 Panasonic: Medical Exoskeleton Portfolio
Table 10.32 Panasonic: Non-Medical Exoskeleton Portfolio
Table 10.33 Panasonic: Recent Developments and Future Outlook
Table 10.34 Tyromotion: Company Snapshot
Table 10.35 Tyromotion: Medical Exoskeleton Portfolio
Table 10.36 Tyromotion: Recent Developments and Future Outlook
Table 11.1 Exoskeleton Developers: List of Companies Profiled
Table 11.2 Bionic Yantra: Company Snapshot
Table 11.3 Bionic Yantra: Medical Exoskeleton Portfolio
Table 11.4 MediTouch: Company Snapshot
Table 11.5 MediTouch: Medical Exoskeleton Portfolio
Table 11.6 Milebot Robotics: Company Snapshot
Table 11.7 Milebot Robotics: Medical Exoskeleton Portfolio
Table 11.8 Milebot Robotics: Non- Medical Exoskeleton Portfolio
Table 11.9 Myomo: Company Snapshot
Table 11.10 Myomo: Medical Exoskeleton Portfolio
Table 11.11 Neofect: Company Snapshot
Table 11.12 Neofect: Medical Exoskeleton Portfolio
Table 11.13 NextStep Robotics: Company Snapshot
Table 11.14 NextStep Robotics: Medical Exoskeleton Portfolio
Table 11.15 ReWalk Robotics: Company Snapshot
Table 11.16 ReWalk Robotics: Medical Exoskeleton Portfolio
Table 11.17 REX Bionics: Company Snapshot
Table 11.18 REX Bionics: Medical Exoskeleton Portfolio
Table 11.19 Roam Robotics: Company Snapshot
Table 11.20 Roam Robotics: Medical Exoskeleton Portfolio
Table 11.21 Roam Robotics: Non-Medical Exoskeleton Portfolio
Table 11.22 Trexo Robotics: Company Snapshot
Table 11.23 Trexo Robotics: Medical Exoskeleton Portfolio
Table 11.24 U&O Technologies: Company Snapshot
Table 11.25 U&O Technologies: Medical Exoskeleton Portfolio
Table 12.1 Medical Exoskeletons: List of Partnerships and Collaborations
Table 13.1 Patent Analysis: Top CPC Sections
Table 13.2 Patent Analysis: Top CPC Symbols
Table 13.3 Patent Analysis: Top CPC Codes
Table 13.4 Patent Analysis: Summary of Benchmarking Analysis
Table 13.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 13.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 13.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 16.1 Average Price of Powered Exoskeletons Used across Different Application Areas
Table 17.1 Estimated Revenues of Medical Exoskeletons, based on Body Part Covered
Table 17.2 Estimated Revenues of Non-Medical Exoskeletons, based on Body Part Covered
Table 18.1 Estimated Revenues of Powered, Passive and Hybrid Exoskeletons from Various Application Areas
Table 19.1 Estimated Revenues of Medical Exoskeletons, based on Form
Table 19.2 Estimated Revenues of Non-Medical Exoskeletons, based on Form
Table 19.3 Estimated Revenues of Medical Exoskeletons, based on Mobility
Table 21.1 Estimated Revenues for Medical Exoskeletons from Various End Users
Table 21.2 Estimated Revenues for Non-Medical Exoskeletons from Various End Users
Table 24.1 ABLE Human Motion: Key Highlights
Table 24.2 Archelis: Key Highlights
Table 24.3 Biomotum: Key Highlights
Table 24.4 Bionic Yantra: Key Highlights
Table 24.5 Bionic Power: Key Highlights
Table 26.1 Medical Exoskeletons: Distribution by Status of Development
Table 26.2 Medical Exoskeletons: Distribution by Type of Body Part Covered
Table 26.3 Medical Exoskeletons: Distribution by Mode of Operation
Table 26.4 Medical Exoskeletons: Distribution by Type of Body Part Covered and Mode of Operation
Table 26.5 Medical Exoskeletons: Distribution by Form of Exoskeleton
Table 26.6 Medical Exoskeletons: Distribution by Mode of Operation and Form of Exoskeleton
Table 26.7 Medical Exoskeletons: Distribution by Type of Body Part Covered and Form of Exoskeleton
Table 26.8 Medical Exoskeletons: Distribution by Device Mobility
Table 26.9 Medical Exoskeletons: Distribution by Mode of Operation and Device Mobility
Table 26.10 Medical Exoskeletons: Distribution by Form of Exoskeleton and Device Mobility
Table 26.11 Medical Exoskeletons: Distribution by Type of Body Part Covered and Device Mobility
Table 26.12 Medical Exoskeletons: Distribution by User-Machine Interface
Table 26.13 Medical Exoskeletons: Distribution by Type of Body Part Covered and User-Machine Interface
Table 26.14 Medical Exoskeletons: Distribution by Mode of Operation and User-Machine Interface
Table 26.15 Medical Exoskeletons: Distribution by Availability of Advanced Features
Table 26.16 Medical Exoskeletons: Distribution by End User
Table 26.17 Medical Exoskeletons: Distribution by Patient Age Group
Table 26.18 Medical Exoskeletons: Distribution by Exoskeleton Setting for Patients
Table 26.19 Medical Exoskeletons: Distribution by Breakthrough Designation
Table 26.20 Medical Exoskeleton Developers: Distribution by Year of Establishment
Table 26.21 Medical Exoskeleton Developers: Distribution by Company Size
Table 26.22 Medical Exoskeleton Developers: Distribution by Company Size and Employee Count
Table 26.23 Medical Exoskeleton Developers: Distribution by Location of Headquarters (Region)
Table 26.24 Medical Exoskeleton Developers: Distribution by Location of Headquarters (Country)
Table 26.25 Medical Exoskeleton Developers: Distribution by Company Size and Location of Headquarters
Table 26.26 Medical Exoskeleton Developers: Distribution by Company Ownership
Table 26.27 Medical Exoskeleton Developers: Distribution by Location of Headquarters and Company Ownership
Table 26.28 Medical Exoskeleton Developers: Distribution by Additional Services Offered
Table 26.29 Most Active Players: Distribution by Number of Medical Exoskeletons
Table 26.30 Non-Medical Exoskeletons: Distribution by Status of Development
Table 26.31 Non-Medical Exoskeletons: Distribution by Type of Body Part Covered
Table 26.32 Non-Medical Exoskeletons: Distribution by Body Part Supported
Table 26.33 Non-Medical Exoskeletons: Distribution by Mode of Operation
Table 26.34 Non-Medical Exoskeletons: Distribution by Form of Exoskeleton
Table 26.35 Non-Medical Exoskeletons: Distribution by Mode of Operation and Form of Exoskeleton
Table 26.36 Non-Medical Exoskeletons: Distribution by Type of Body Part Covered and Mode of Operation
Table 26.37 Non-Medical Exoskeletons: Distribution by Mode of Operation and Form of Exoskeleton
Table 26.38 Non-Medical Exoskeletons: Distribution by Type of Body Part Covered and Form of Exoskeleton
Table 26.39 Non-Medical Exoskeletons: Distribution by Application Area
Table 26.40 Non-Medical Exoskeletons: Distribution by Mode of Operation and Application Area
Table 26.41 Non-Medical Exoskeletons Developers: Distribution by Year of Establishment
Table 26.42 Non-Medical Exoskeleton Developers: Distribution by Company Size
Table 26.43 Non-Medical Exoskeleton Developers: Distribution by Company Size and Employee Count
Table 26.44 Non-Medical Exoskeleton Developers: Distribution by Location of Headquarters (Region)
Table 26.45 Non-Medical Exoskeleton Developers: Distribution by Location of Headquarters (Country)
Table 26.46 Non-Medical Exoskeleton Developers: Distribution by Company Size and Location of Headquarters
Table 26.47 Non-Medical Exoskeleton Developers: Distribution by Company Ownership
Table 26.48 Non-Medical Exoskeleton Developers: Distribution by Location of Headquarters and Company Ownership
Table 26.49 Most Active Players: Distribution by Number of Non-Medical Exoskeletons
Table 26.50 Most Active Players: Distribution by Number of Medical and Non-Medical Exoskeletons
Table 26.51 CYBERDYNE: Annual Revenues, Since FY 2019 (JPY Billion)
Table 26.52 CYBERDYNE: Distribution of Annual Revenues by Business Segment, Since FY 2021 (JPY Billion)
Table 26.53 Ekso Bionics: Annual Revenues, Since FY 2018 (USD Billion)
Table 26.54 Ekso Bionics: Distribution of Annual Revenues by Business Segment, FY 2023
Table 26.55 Panasonic: Annual Revenues, Since FY 2018 (JPY Billion)
Table 26.56 Partnerships and Collaborations: Cumulative Year-wise Trend
Table 26.57 Partnerships and Collaborations: Distribution by Type of Partnership
Table 26.58 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 26.59 Partnerships and Collaborations: Distribution by Purpose of Partnership
Table 26.60 Partnerships and Collaborations: Distribution by Type and Purpose of Partnership
Table 26.61 Partnerships and Collaborations: Distribution by Type of Partner
Table 26.62 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Table 26.63 Partnerships and Collaborations: Type of Non-Industry Partner
Table 26.64 Most Active Players: Distribution by Number of Partnerships
Table 26.65 Partnerships and Collaborations: Local and International Agreements
Table 26.66 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Table 26.67 Patent Analysis: Distribution by Type of Patent
Table 26.68 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year
Table 26.69 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year
Table 26.70 Patent Analysis: Distribution by Type of Patent and Patent Publication Year
Table 26.71 Patent Analysis: Distribution by Publication Time
Table 26.72 Patent Analysis: Distribution by Patent Jurisdiction (Region)
Table 26.73 Patent Analysis: Distribution by Patent Jurisdiction (Country)
Table 26.74 Patent Analysis: Distribution by Type of Applicant
Table 26.75 Leading Industry Players: Distribution by Number of Patents
Table 26.76 Leading Non-Industry Players: Distribution by Number of Patents
Table 26.77 Leading Individual Assignees: Distribution by Number of Patents
Table 26.78 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Table 26.79 Leading Non-Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Table 26.80 Patent Analysis: Distribution by Patent Age
Table 26.81 Patent Analysis: Patent Valuation
Table 26.82 Global Exoskeletons Market, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.83 Global Exoskeletons Market, Forecasted Estimates (Till 2035) Conservative Scenario (USD Billion)
Table 26.84 Global Exoskeletons Market, Forecasted Estimates (Till 2035), Optimistic Scenario (USD Billion)
Table 26.85 Medical Exoskeletons Market: Distribution by Body Part Covered (USD Billion)
Table 26.86 Medical Upper Body Exoskeleton Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.87 Medical Lower Body Exoskeleton Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.88 Medical Full Body Exoskeleton Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.89 Non-Medical Upper Body Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (2023- 2035) (USD Billion)
Table 26.90 Non-Medical Lower Body Exoskeleton Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.91 Non-Medical Full Body Exoskeleton Market Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
Table 26.92 Overall Exoskeletons Market: Distribution by Body Part Covered (USD Billion)
Table 26.93 Overall Upper Body Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.94 Overall Lower Body Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.95 Overall Full Body Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.96 Medical Exoskeletons Market: Distribution by Mode of Operation (USD Billion)
Table 26.97 Medical Powered Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.98 Medical Passive Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.99 Medical Hybrid Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.100 Non-Medical Exoskeletons Market: Distribution by Mode of Operation (USD Billion)
Table 26.101 Non-Medical Powered Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (2023- 2035) (USD Billion)
Table 26.102 Non-Medical Passive Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.103 Non-Medical Hybrid Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.104 Overall Powered Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (2023- 2035) (USD Billion)
Table 26.105 Overall Passive Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.106 Overall Hybrid Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.107 Medical Exoskeletons Market: Distribution by Form (USD Billion)
Table 26.108 Medical Rigid Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.109 Medical Soft Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.110 Non-Medical Exoskeletons Market: Distribution by Form, 2018, 2023 and 2035 (USD Billion)
Table 26.111 Non-Medical Rigid Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.112 Non-Medical Soft Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.113 Overall Exoskeletons Market: Distribution by Form (USD Billion)
Table 26.114 Overall Rigid Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
Table 26.115 Overall Soft Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.116 Medical Fixed / Supported Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.117 Medical Mobile / Overground Walking Exoskeletons Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.118 Overall Exoskeletons Market: Distribution by End Users (USD Billion)
Table 26.119 Medical Exoskeletons Market by Patients: Historical Trends (Since 2018) and Forecasted Estimates (2023- 2035) (USD Billion)
Table 26.120 Medical Exoskeletons Market by Healthcare Professionals: Historical Trends (Since 2018) and Forecasted Estimates (2023- 2035) (USD Billion)
Table 26.121 Non-Medical Exoskeletons Market by Industry Workers: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.122 Non-Medical Exoskeletons Market by Military Personnel: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.123 Non-Medical Exoskeletons Market by Other End Users: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
Table 26.124 Exoskeletons Market in North America: Historical Trends (Since 2018) Forecasted Estimates (2023- 2035) (USD Billion)
Table 26.125 Exoskeletons Market in Europe: Historical Trends (Since 2018) Forecasted Estimates (2023- 2035) (USD Billion)
Table 26.126 Exoskeleton Market in Asia-Pacific: Historical Trends (Since 2018) Forecasted Estimates (Till 2035) (USD Billion)
Table 26.127 Exoskeleton Market in Rest of the World: Historical Trends (Since 2018) Forecasted Estimates (Till 2035) (USD Billion)